Silvana Am Urru1, Antonello Antonelli2, Giuseppe M Sechi2. 1. Biosciences Sector, CRS4, Science and Technology Park Polaris-Piscina Manna, Pula, Italy. 2. Department of Clinical Governance, Sardinia Region Health Service, Cagliari, Italy.
Abstract
BACKGROUND: Partial surveys in sub-regions of Sardinia have suggested a high prevalence of multiple sclerosis (MS) on the island, relative to other Mediterranean populations. We assessed the island-wide prevalence of MS and its detailed distribution in Sardinia. METHODS: The study population consisted of 5677 MS patients, 1735 men and 3942 women, living in Sardinia. Neurologists retrospectively examined electronic and paper-based records of patients with a diagnosis of MS. The data were then linked to the administrative health information systems. Crude, age-, and sex-specific prevalence estimates of disease were calculated. RESULTS: The overall age-adjusted MS prevalence was 330 per 100,000 (95% confidence interval (CI) 321-338) in individuals older than 15 years, 447 in women (95% CI 433-461), and 205 in men (95% CI 195-214). The prevalence was highest in the Ogliastra and Nuoro districts, respectively, 425 (95% CI 372-478) and 419 (95% CI 387-451), and lowest in the Olbia-Tempio district, 217 (95% CI 195-239). Most cases had relapsing-remitting MS (79.3%), 16.3% had secondary-progressive MS, and 4.4% had primary-progressive MS. CONCLUSION: These prevalence are among the highest reported so far worldwide. They provide estimates for comparative analyses in other populations and are essential for public health interventions.
BACKGROUND: Partial surveys in sub-regions of Sardinia have suggested a high prevalence of multiple sclerosis (MS) on the island, relative to other Mediterranean populations. We assessed the island-wide prevalence of MS and its detailed distribution in Sardinia. METHODS: The study population consisted of 5677 MS patients, 1735 men and 3942 women, living in Sardinia. Neurologists retrospectively examined electronic and paper-based records of patients with a diagnosis of MS. The data were then linked to the administrative health information systems. Crude, age-, and sex-specific prevalence estimates of disease were calculated. RESULTS: The overall age-adjusted MS prevalence was 330 per 100,000 (95% confidence interval (CI) 321-338) in individuals older than 15 years, 447 in women (95% CI 433-461), and 205 in men (95% CI 195-214). The prevalence was highest in the Ogliastra and Nuoro districts, respectively, 425 (95% CI 372-478) and 419 (95% CI 387-451), and lowest in the Olbia-Tempio district, 217 (95% CI 195-239). Most cases had relapsing-remitting MS (79.3%), 16.3% had secondary-progressive MS, and 4.4% had primary-progressive MS. CONCLUSION: These prevalence are among the highest reported so far worldwide. They provide estimates for comparative analyses in other populations and are essential for public health interventions.
Authors: Andrea Nova; Teresa Fazia; Ashley Beecham; Valeria Saddi; Marialuisa Piras; Jacob L McCauley; Carlo Berzuini; Luisa Bernardinelli Journal: Life (Basel) Date: 2022-01-20
Authors: Patrick Ostkamp; Anke Salmen; Béatrice Pignolet; Dennis Görlich; Till F M Andlauer; Andreas Schulte-Mecklenbeck; Gabriel Gonzalez-Escamilla; Florence Bucciarelli; Isabelle Gennero; Johanna Breuer; Gisela Antony; Tilman Schneider-Hohendorf; Nadine Mykicki; Antonios Bayas; Florian Then Bergh; Stefan Bittner; Hans-Peter Hartung; Manuel A Friese; Ralf A Linker; Felix Luessi; Klaus Lehmann-Horn; Mark Mühlau; Friedemann Paul; Martin Stangel; Björn Tackenberg; Hayrettin Tumani; Clemens Warnke; Frank Weber; Brigitte Wildemann; Uwe K Zettl; Ulf Ziemann; Bertram Müller-Myhsok; Tania Kümpfel; Luisa Klotz; Sven G Meuth; Frauke Zipp; Bernhard Hemmer; Reinhard Hohlfeld; David Brassat; Ralf Gold; Catharina C Gross; Carsten Lukas; Sergiu Groppa; Karin Loser; Heinz Wiendl; Nicholas Schwab Journal: Proc Natl Acad Sci U S A Date: 2021-01-05 Impact factor: 11.205
Authors: Anje Cauwels; Sandra Van Lint; Elke Rogge; Annick Verhee; Bram Van Den Eeckhout; Shengru Pang; Marco Prinz; Niko Kley; Gilles Uzé; Jan Tavernier Journal: Sci Rep Date: 2021-11-03 Impact factor: 4.379
Authors: Ruggiero Seccia; Daniele Gammelli; Fabio Dominici; Silvia Romano; Anna Chiara Landi; Marco Salvetti; Andrea Tacchella; Andrea Zaccaria; Andrea Crisanti; Francesca Grassi; Laura Palagi Journal: PLoS One Date: 2020-03-20 Impact factor: 3.240